Synthaverse Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Synthaverse.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 42.4% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Optimistic Investors Push Synthaverse S.A. (WSE:SVE) Shares Up 32% But Growth Is Lacking
Apr 20
Why Synthaverse's (WSE:SVE) Soft Earnings Are Just The Beginning Of Its Problems
Apr 18BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek (WSE:BML) Seems To Use Debt Quite Sensibly
Oct 14More Unpleasant Surprises Could Be In Store For BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A.'s (WSE:BML) Shares After Tumbling 48%
Nov 29We Think You Should Be Aware Of Some Concerning Factors In BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek's (WSE:BML) Earnings
Nov 16Does BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek (WSE:BML) Deserve A Spot On Your Watchlist?
May 02Is BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek (WSE:BML) A Risky Investment?
Mar 08What Percentage Of BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (WSE:BML) Shares Do Insiders Own?
Jan 29
Should Weakness in BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A.'s (WSE:BML) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Jan 03BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek (WSE:BML) Takes On Some Risk With Its Use Of Debt
Dec 07In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Synthaverse has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2024 | 63 | 4 | -58 | 15 | N/A |
| 6/30/2024 | 57 | 2 | -102 | 6 | N/A |
| 3/31/2024 | 61 | 4 | -118 | 1 | N/A |
| 12/31/2023 | 59 | 5 | -118 | -5 | N/A |
| 9/30/2023 | 53 | 3 | -97 | -6 | N/A |
| 6/30/2023 | 58 | 7 | -68 | -2 | N/A |
| 3/31/2023 | 54 | 7 | -43 | 2 | N/A |
| 12/31/2022 | 50 | 6 | -34 | 3 | N/A |
| 9/30/2022 | 51 | 7 | -30 | 0 | N/A |
| 6/30/2022 | 44 | 4 | -26 | -6 | N/A |
| 3/31/2022 | 44 | 5 | -19 | -4 | N/A |
| 12/31/2021 | 41 | 4 | -22 | -3 | N/A |
| 9/30/2021 | 39 | 5 | -11 | 1 | N/A |
| 6/30/2021 | 40 | 5 | -1 | 4 | N/A |
| 3/31/2021 | 35 | 2 | -4 | 0 | N/A |
| 12/31/2020 | 40 | 4 | -2 | 0 | N/A |
| 9/30/2020 | 41 | 2 | -4 | -2 | N/A |
| 6/30/2020 | 40 | 3 | 3 | 4 | N/A |
| 3/31/2020 | 40 | 3 | 4 | 5 | N/A |
| 12/31/2019 | 39 | 2 | 7 | 8 | N/A |
| 9/30/2019 | 35 | -29 | 8 | 10 | N/A |
| 6/30/2019 | 36 | -31 | 1 | 3 | N/A |
| 3/31/2019 | 35 | -32 | 4 | 7 | N/A |
| 12/31/2018 | 32 | -32 | -3 | -1 | N/A |
| 9/30/2018 | 31 | 10 | -2 | -5 | N/A |
| 6/30/2018 | 31 | 11 | N/A | -2 | N/A |
| 3/31/2018 | 30 | 1 | N/A | -2 | N/A |
| 12/31/2017 | 31 | 1 | N/A | 4 | N/A |
| 9/30/2017 | 31 | -23 | N/A | 31 | N/A |
| 6/30/2017 | 32 | -27 | N/A | 30 | N/A |
| 3/31/2017 | 37 | -26 | N/A | 10 | N/A |
| 12/31/2016 | 36 | -26 | N/A | 16 | N/A |
| 9/30/2016 | 46 | -48 | N/A | -4 | N/A |
| 6/30/2016 | 45 | -45 | N/A | -15 | N/A |
| 3/31/2016 | 47 | -35 | N/A | 5 | N/A |
| 12/31/2015 | 43 | -37 | N/A | -3 | N/A |
| 9/30/2015 | 38 | -2 | N/A | -5 | N/A |
| 6/30/2015 | 36 | -2 | N/A | 2 | N/A |
| 3/31/2015 | 31 | -2 | N/A | 1 | N/A |
| 12/31/2014 | 34 | 0 | N/A | -1 | N/A |
| 9/30/2014 | 28 | -3 | N/A | -9 | N/A |
| 6/30/2014 | 29 | 0 | N/A | -7 | N/A |
| 3/31/2014 | 31 | 0 | N/A | -7 | N/A |
| 12/31/2013 | 33 | 1 | N/A | -7 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if SVE's forecast earnings growth is above the savings rate (4.1%).
Earnings vs Market: Insufficient data to determine if SVE's earnings are forecast to grow faster than the Polish market
High Growth Earnings: Insufficient data to determine if SVE's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if SVE's revenue is forecast to grow faster than the Polish market.
High Growth Revenue: Insufficient data to determine if SVE's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SVE's Return on Equity is forecast to be high in 3 years time